Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients.
about
Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.Clinical outcome measures for cutaneous lupus erythematosus.Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial.Prevalence of self-report photosensitivity in cutaneous lupus erythematosus.Identification and molecular analysis of glycosaminoglycans in cutaneous lupus erythematosus and dermatomyositis.Cigarette smoking and response to antimalarials in cutaneous lupus erythematosus patients: evolution of a dogma.Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis.Lenalidomide therapy in treatment-refractory cutaneous lupus erythematosus: histologic and circulating leukocyte profile and potential risk of a systemic lupus flare.Impact of smoking in cutaneous lupus erythematosus.The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus.The impact of skin damage due to cutaneous lupus on quality of lifeCutaneous lupus erythematosus: diagnosis and treatment.Rheumatic manifestations of skin disease.Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates.New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.Quinacrine Suppresses Tumor Necrosis Factor-α and IFN-α in Dermatomyositis and Cutaneous Lupus Erythematosus.Lupus community panel proposals for optimising clinical trials: 2018.Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus.
P2860
Q34548422-2C428CFC-3AFA-4429-8382-2DC5D7FE2094Q34844623-DC5A9EDF-7E54-4467-A2D3-6A939D8FE41AQ35097266-4E9F2964-409A-412C-BF92-01F34A0DB60CQ35353447-08A2A169-BF12-45DB-BE7F-E1F4E0BC68BCQ35440942-C09537F4-5EF0-4FF0-8F41-95B5D1C17E04Q35686749-164BF8F9-BDE0-47D5-BFF5-A9E75F6C2D52Q35764302-B3985EC0-F976-4F72-8D94-681300A9E03FQ35836605-89508433-9F6A-4A15-B9E9-61D561220A77Q35842894-3E0B0625-BD10-476D-BAD5-C345A50EC3F7Q35911498-4760CC9B-DCCA-4E2D-ABEA-CC568DD36882Q36306426-210244EE-6133-4A6C-8852-D7B11AA4C20CQ36932364-8CF11535-9FAF-4614-B2FC-C29EE785DCEFQ37590352-31930E83-FCBE-4F88-8E0E-88414778FEDDQ37620086-3DA4D453-D9C1-4F5A-939A-8C95C86D2D5EQ37778645-D17B3987-F786-47D7-9B73-99337D3F74D5Q38026787-AFCF6910-D760-466B-BFD3-5EA1DDA4FF20Q47760514-BBCB2570-A3E9-4457-A37B-5313DE7EE802Q52320880-D39D6681-9845-40BD-8554-EDD5DC35DECBQ54372699-9123FCE9-2731-417C-ABCA-0A10D49963E6
P2860
Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cross-sectional analysis of a ...... ve enrollment of 114 patients.
@ast
Cross-sectional analysis of a ...... ve enrollment of 114 patients.
@en
type
label
Cross-sectional analysis of a ...... ve enrollment of 114 patients.
@ast
Cross-sectional analysis of a ...... ve enrollment of 114 patients.
@en
prefLabel
Cross-sectional analysis of a ...... ve enrollment of 114 patients.
@ast
Cross-sectional analysis of a ...... ve enrollment of 114 patients.
@en
P2093
P2860
P1433
P1476
Cross-sectional analysis of a ...... ve enrollment of 114 patients.
@en
P2093
Elizabeth Gaines
Joyce Okawa
Katherine Chilek
Mathew E Rose
Melissa Costner
Siamak Moghadam-Kia
Victoria P Werth
P2860
P304
P356
10.1001/ARCHDERMATOL.2008.594
P577
2009-03-01T00:00:00Z